BC
WST icon

Brookfield Corp’s West Pharmaceutical WST Stock Holding History

Brookfield Corp’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15,526
Closed -$5.94M – 530
2023
Q2 		$5.94M Buy
15,526
+5,657
+57% +$2.02M 0.02% 244
2023
Q1 		$3.42M Buy
+9,869
New +$2.88M 0.01% 355
2022
Q4 		– Sell
-4,256
Closed -$1.05M – 755
2022
Q3 		$1.05M Sell
4,256
-2,102
-33% -$640K ﹤0.01% 529
2022
Q2 		$1.92M Buy
+6,358
New +$2.07M 0.01% 422
2021
Q1 		– Sell
-7,062
Closed -$2M – 583
2020
Q4 		$2M Buy
7,062
+2,140
+43% +$601K 0.01% 287
2020
Q3 		$1.35M Sell
4,922
-15,135
-75% -$4.01M 0.01% 282
2020
Q2 		$4.56M Buy
+20,057
New +$3.94M 0.03% 145

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Brookfield Corp's WST Position: Q3 2023 in Review

Brookfield Corp sold out of West Pharmaceutical (WST) in Q3 2023, closing a stake of 15,526 shares — an estimated $5.94M sold.

Brookfield Corp first reported a position in WST in Q2 2020 and held it in 7 quarters. The position peaked at $5.94M in Q2 2023. 757 funds tracked by Wall St. Rank hold WST as of Q3 2023.

  • Brookfield Corp reported no remaining West Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • Brookfield Corp sold 15,526 West Pharmaceutical shares in Q3 2023, an estimated $5.94M.
  • Brookfield Corp first reported a position in West Pharmaceutical in Q2 2020 and held it in 7 quarters.
  • Brookfield Corp's West Pharmaceutical position peaked at $5.94M in Q2 2023.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2023.

Based on Brookfield Corp's 13F filing for Q3 2023, filed 14 Nov 2023.